ClinicalTrials.govpublic full text
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
mac lung disease, treatment refractory mac lung disease, mycobacterium infections, nontuberculous, bronchiectasis, ntm (nontuberculous mycobacteria), mac (mycobacterium avium complex), mabsc (mycobacterium abscessus complex), pulmonary nontuberculous mycobacteria, respiratory infection, antimycobacterial activity, antimycobacterial therapy, mac infections
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 806514
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.